Minulet (Ethinylestradiol, Gestodene)

• Minulet, a combined oral contraceptive, is indicated for hormonal regulation of the reproductive system to prevent pregnancy.
• Contraception: Prevents unintended pregnancy when taken as directed.
• Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding and reduces menstrual flow.
• Acne management: Can improve mild to moderate acne associated with hormonal fluctuations.

• Minulet combines ethinylestradiol, a synthetic estrogen, with gestodene, a progestogen. The estrogen component suppresses the surge of luteinizing hormone, while the progestogen inhibits follicular development and stabilizes the endometrium. Together they prevent ovulation, thicken cervical mucus to impede sperm penetration, and alter the uterine lining, making implantation unlikely.

Like all hormonal contraceptives, Minulet may cause adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

• Nausea: mild stomach upset, especially during the first cycles.
• Headache: tension‑type or migraine‑like headaches.
• Breast tenderness: temporary swelling or discomfort.
• Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins or lungs.
• Hypertensive disorders: significant increase in blood pressure.
• Liver dysfunction: abnormal liver enzymes or jaundice.

• Before prescribing Minulet, clinicians should evaluate several safety considerations to minimize risks.
• Contraindications: Do not use in women with a history of thromboembolic disorders, estrogen‑dependent tumors, or active liver disease.
• Smoking: Avoid in smokers over 35 years due to increased cardiovascular risk.
• Cardiovascular risk: Assess for hypertension, hyperlipidemia, or coronary artery disease before initiation.
• Pregnancy: Must not be taken during pregnancy; discontinue immediately if pregnancy occurs.
• Drug interactions: Review concomitant medications that may reduce efficacy or increase clot risk.
• Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture and light.

Minulet can interact with other medicines, altering its effectiveness or increasing adverse event risk.

Major Interactions (Avoid)

• Anticoagulants: May reduce efficacy of warfarin, requiring closer INR monitoring.
• Enzyme inducers: Rifampicin, carbamazepine, and phenytoin can lower hormone levels, risking contraceptive failure.
• Selective serotonin reuptake inhibitors (SSRIs): Certain SSRIs may increase the risk of serotonin syndrome when combined with hormonal agents.

Moderate Interactions (Monitor Closely)

• Antiepileptics: Valproic acid may affect hormone metabolism, requiring efficacy monitoring.
• Antibiotics: Some broad‑spectrum antibiotics may slightly reduce contraceptive effectiveness; advise backup contraception.
• Herbal supplements: St. John’s wort can induce hepatic enzymes, potentially decreasing hormone levels.